However, in premenopausal women treated with ovarian function suppression or ablation, another efficacious endocrine treatment,3 this physiological response is overcome and aromatase inhibitors might, therefore, also be more efficacious than tamoxifen at preventing breast cancer recurrence.4 The gene discussed is CYP19A1; the disease is breast cancer.